Conference Committees
IPVC 2024 Co-Chairs
Suzanne Garland
AustraliaDepartment of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia
Kate Cuschieri
UKSheila Graham
UKIPVC 2024 Organizing Committee
Suzanne Garland
AustraliaDepartment of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia
Michelle Adair Ozbun
USAProfessor, Departments of Molecular Genetics & Microbiology; Obstetrics and Gynecology, The University of New Mexico School of Medicine Co-Leader, Head and Neck Cancer Clinical Working Group, The University of New Mexico Comprehensive Cancer Center
Anna R. Giuliano
USAAnna R. Giuliano, PhD
Professor and Director
Center for Immunization and Infection Research in Cancer (CIIRC)
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
Anna R. Giuliano, PhD, is the founding director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center in Tampa, Florida. Dr Giuliano’s career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer, and has evolved over the past 30 years to encompass penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. Her work has contributed significantly to our understanding of HPV natural history and to HPV vaccine protection against multiple diseases in women and men.
An expert in the field of cancer research she has led numerous studies conducted globally. Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report that concluded for the first time that HPV is a cause of multiple cancers in women and men. In 2013, at the American Cancer Society (ACS) 100th anniversary, she was the recipient of the ACS Distinguished Achievement in Cancer Award. In 2018, she was selected for the ACS Clinical Research Professor Award for “Prevention of Infection-Related Cancers.” In 2019, Dr. Giuliano received the American Society of Preventive Oncology (ASPO) Fraumeni Distinguished Lifetime Achievement Award.
Dr Giuliano has authored >400 peer-reviewed publications.
Sheila Graham
UKMargaret Stanley
United Kingdom Co-ChairMargaret Stanley is Emeritus Professor of Epithelial Biology in the University of Cambridge
and Honorary Fellow of Christs College, Cambridge. She has a lifetime award
for contribution to research on cervical cancer and cervical precancers from the American
Society for Colposcopy and Cytopathology (ASCCP) and a lifetime award for achievement
from the IPVS.
Kate Cuschieri
UKAimee Kreimer
USAInfectious Disease Epidemiologist
Senior Investigator, Division of Cancer Epidemiology and Genetics
US National Cancer Institute
National Institutes of Health
Sharon Hanley
UKBasic Science Committee
Margaret Stanley
United KingdomMargaret Stanley is Emeritus Professor of Epithelial Biology in the University of Cambridge
and Honorary Fellow of Christs College, Cambridge. She has a lifetime award
for contribution to research on cervical cancer and cervical precancers from the American
Society for Colposcopy and Cytopathology (ASCCP) and a lifetime award for achievement
from the IPVS.
Andrew Macdonald
United KingdomClinical Science Committee
Sarah Feldman
USAMaggie Cruickshank
UKOmenge Orang'o
Ida Ismail Pratt
Rebecca Luckett
Nancy Pena
Public Health, Epidemiology & Implementation Science Committee
Anna R. Giuliano
IPVS President-ElectIPVC 2024 Public Health Co-Chair
Sharon Hanley
UKAwareness Committee
Joel Palefsky
USAM.D., C.M., F.R.C.P.(C). Professor of Medicine at the University of California San Francisco School of Medicine. His interests include the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer. He is the founder and past president of the International Anal Neoplasia Society and is the past president of the International Papillomavirus Society (IPVS). He continues to serve on the board of IPVS and leads the IPVS International HPV Awareness Day Campaign.
Yin Ling Woo
MalaysiaEarly Career Researcher (ECR) Committee
Talía Malagón
CanadaDr. Talía Malagón is an epidemiologist, mathematical modeller, and academic associate in the Gerald Bronfman Department of Oncology at McGill University. Her research projects include understanding the predictors of human papillomavirus transmission between sexual partners, risk factors for cervical precancer, and decision modeling to evaluate the balance of screening harms and benefits of cervical cancer screening, and health inequalities in cancer incidence and cancer care pathways. Dr. Malagón is a member of the McGill Department of Oncology COVID-19 and Cancer Program, whose goal is to generate evidence to assess the impact of the COVID-19 pandemic on cancer-related services across its network and inform decision-making for the resumption and improvement of cancer-related services. Dr. Malagón has a Ph.D. in epidemiology from Université Laval (2016). She teaches graduate-level and resident courses in cancer epidemiology in the Departments of Oncology and the Department of Epidemiology, Biostatistics, and Occupational Health. She is a senior editor of Cancer Epidemiology, Biomarkers & Prevention (2022-), a reviewing editor at eLife (2020-), and a Board member of the International Papillomavirus Society.